Paras Biopharmaceuticals Finland Oy

This company's activities and offerings span three major areas: contract development and microbial biologics manufacturing (CDMO), providing end-to-end services for producing microbial recombinant proteins; development of recombinant expression systems and process technologies for biologics and biosimilars, including recombinant IL1-RA/Anakinra (a Kineret biosimilar) and recombinant Romiplostim (an Nplate biosimilar); and recombinant bioprocess enzymes, offering enterokinase and TEV protease.